Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance-Reference-Cited by-同舟云学术

Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance

Published:2010-10 Issue:1 Volume:296 Page:65-73
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhi Lei,Wang Min,Rao Qing,Yu Fan,Mi Yingchang,Wang Jianxiang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. Human acute myeloid leukemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities;Costello;Cancer Res.,2000

2. Leukaemia stem cells and the evolution of cancer-stem-cell research;Huntly;Nat. Rev. Cancer,2005

3. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat. Med.,1997

4. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice;Lapidot;Nature,1994

5. During ontogeny primitive (CD34(+)CD38(−)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts;Oh;Blood,2000

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sweet symphony of N-glycans in myeloid malignancies;Frontiers in Hematology;2024-07-08

2. Epithelial–Mesenchymal Transition in Acute Leukemias;International Journal of Molecular Sciences;2024-02-11

3. The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia;International Journal of Cancer;2023-08-11

4. Microfluidic chip with reversible interface for noninvasive remission status monitoring and prognosis prediction of acute myeloid leukemia;Biosensors and Bioelectronics;2023-01

5. Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia;Expert Reviews in Molecular Medicine;2023